The relationship between IGFBP-1 and MACE is complex, given studies suggesting that lower levels are associated with poor metabolic profiles and IGFBP-1 overexpression can be protective against atherosclerosis [53,54]. The gene discussed is IGFBP1; the disease is atherosclerosis.